Open Access
Issue
Med Sci (Paris)
Volume 37, Number 2, Février 2021
Page(s) 130 - 133
Section Le Magazine
DOI https://doi.org/10.1051/medsci/2020276
Published online 16 February 2021
  1. Kaplon H, Dieu-Nosjean MC. Quel avenir pour les lymphocytes B infiltrant les tumeurs solides : marqueur pronostique et/ou cible thérapeutique ?. Med Sci (Paris) 2018 ; 34 : 72–78. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008 ; 26 : 4410–4417. [CrossRef] [PubMed] [Google Scholar]
  3. Germain C, Gnjatic S, Tamzalit F, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med 2014 ; 189 : 832–844. [CrossRef] [PubMed] [Google Scholar]
  4. Teillaud JL, Dieu-Nosjean MC. Tertiary lymphoid structures: An anti-tumor school for adaptive immune cells and an antibody factory to fight cancer?. Front Immunol 2017 ; 8 : 830. [CrossRef] [PubMed] [Google Scholar]
  5. Cottrell TR, Thompson ED, Forde PM, et al. Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC). Ann Oncol 2018 ; 29 : 1853–1860. [CrossRef] [PubMed] [Google Scholar]
  6. Amaria RN, Reddy SM, Tawbi HA, et al. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med 2018 ; 24 : 1649–1654. [CrossRef] [PubMed] [Google Scholar]
  7. Reddy SM, Reuben A, Barua S, et al. Poor response to neoadjuvant chemotherapy correlates with mast cell infiltration in inflammatory breast cancer. Cancer Immunol Res 2019 ; 7 : 1025–1035. [CrossRef] [PubMed] [Google Scholar]
  8. Song IH, Heo SH, Bang WS, et al. Predictive value of tertiary lymphoid structures assessed by high endothelial venule counts in the neoadjuvant setting of triple-negative breast cancer. Cancer Res Treat 2017 ; 49 : 399–407. [Google Scholar]
  9. Cabrita R, Lauss M, Sanna A, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 2020; 577 : 561–5. [CrossRef] [PubMed] [Google Scholar]
  10. Helmink BA, Reddy SM, Gao J, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 2020; 577 : 549–55. [CrossRef] [PubMed] [Google Scholar]
  11. Petitprez F, de Reyniès A, Keung EZ, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 2020; 577 : 556–60. [CrossRef] [PubMed] [Google Scholar]
  12. Picard E, Verschoor CP, Ma GW, Pawelec G. Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer. Front Immunol 2020; 11 : 369. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.